NasdaqGM - Nasdaq Real Time Price USD
Xencor, Inc. (XNCR)
8.06
0.00
(0.00%)
At close: May 19 at 4:00:01 PM EDT
8.06
0.00
(0.00%)
After hours: May 19 at 4:05:16 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 273,392 | 8 |
Sales | 110,084 | 8 |
Net Shares Purchased (Sold) | 163,308 | 16 |
Total Insider Shares Held | 865.44k | -- |
% Net Shares Purchased (Sold) | 23.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
VALENTE NANCY M.D. Officer | Sale at price 11.03 per share. | Direct | 50,914 | May 2, 2025 |
CORNELISSEN BART JAN Chief Financial Officer | Sale at price 8.06 per share. | Direct | 30,233 | Apr 10, 2025 |
DESJARLAIS JOHN R Officer | Sale at price 13.60 per share. | Direct | 131,851 | Mar 10, 2025 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Sale at price 13.60 per share. | Direct | 268,080 | Mar 10, 2025 |
ECKERT CELIA E General Counsel | Sale at price 13.60 per share. | Direct | 78,047 | Mar 10, 2025 |
VALENTE NANCY M.D. Officer | Sale at price 13.60 per share. | Direct | 34,877 | Mar 10, 2025 |
CORNELISSEN BART JAN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
DESJARLAIS JOHN R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
ECKERT CELIA E General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
DESJARLAIS JOHN R Officer | Conversion of Exercise of derivative security at price 15.69 per share. | Direct | 55,574 | Feb 3, 2025 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Conversion of Exercise of derivative security at price 15.69 per share. | Direct | 138,198 | Feb 3, 2025 |
MONTGOMERY ALAN BRUCE Director | Sale at price 27.03 per share. | Direct | 397,931 | Dec 4, 2024 |
MONTGOMERY ALAN BRUCE Director | Conversion of Exercise of derivative security at price 15.35 - 20.00 per share. | Direct | 251,269 | Dec 4, 2024 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Conversion of Exercise of derivative security at price 15.69 per share. | Direct | 985,740 | Nov 22, 2024 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Sale at price 24.07 per share. | Direct | 1,186,363 | Nov 21, 2024 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Sale at price 24.02 per share. | Direct | 80,842 | Nov 13, 2024 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Conversion of Exercise of derivative security at price 15.69 per share. | Direct | 52,813 | Nov 13, 2024 |
DESJARLAIS JOHN R Officer | Conversion of Exercise of derivative security at price 15.69 per share. | Direct | 1,278,076 | Nov 12, 2024 |
DESJARLAIS JOHN R Officer | Sale at price 23.48 per share. | Direct | 1,612,639 | Nov 11, 2024 |
ROSA-BJORKESON DAGMAR Director | Sale at price 20.68 per share. | Direct | 51,762 | Sep 27, 2024 |
FEIGAL ELLEN G. Director | Sale at price 20.68 per share. | Direct | 51,762 | Sep 27, 2024 |
MONTGOMERY ALAN BRUCE Director | Sale at price 20.68 per share. | Direct | 38,320 | Sep 27, 2024 |
RANIERI RICHARD J Director | Sale at price 20.68 per share. | Direct | 51,762 | Sep 27, 2024 |
GORMAN KEVIN CHARLES Director | Sale at price 20.68 per share. | Direct | 54,885 | Sep 27, 2024 |
GUSTAFSON KURT A Director | Sale at price 20.68 per share. | Direct | 51,762 | Sep 27, 2024 |
DESJARLAIS JOHN R Officer | Conversion of Exercise of derivative security at price 10.73 per share. | Direct | 536,500 | Jul 10, 2024 |
DESJARLAIS JOHN R Officer | Sale at price 18.32 per share. | Direct | 665,511 | Jul 9, 2024 |
MONTGOMERY ALAN BRUCE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
RANIERI RICHARD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
GORMAN KEVIN CHARLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
GUSTAFSON KURT A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
ROSA-BJORKESON DAGMAR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
KLENCKE BARBARA M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
FEIGAL ELLEN G. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2024 |
VALENTE NANCY M.D. Officer | Sale at price 23.58 per share. | Direct | 111,872 | May 2, 2024 |
CORNELISSEN BART JAN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 9, 2024 |
DESJARLAIS JOHN R Officer | Sale at price 23.50 per share. | Direct | 30,082 | Mar 11, 2024 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Sale at price 23.50 per share. | Direct | 64,418 | Mar 11, 2024 |
ECKERT CELIA E General Counsel | Sale at price 23.50 per share. | Direct | 19,977 | Mar 11, 2024 |
KUCH JOHN J Chief Financial Officer | Sale at price 23.50 per share. | Direct | 19,953 | Mar 11, 2024 |
GUSTAFSON KURT A Director | Sale at price 23.18 per share. | Direct | 324,453 | Mar 6, 2024 |
GUSTAFSON KURT A Director | Conversion of Exercise of derivative security at price 10.73 per share. | Direct | 160,950 | Mar 6, 2024 |
DESJARLAIS JOHN R Officer | Sale at price 23.43 per share. | Direct | 155,311 | Mar 5, 2024 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Sale at price 23.43 per share. | Direct | 293,519 | Mar 5, 2024 |
ECKERT CELIA E General Counsel | Sale at price 23.43 per share. | Direct | 91,186 | Mar 5, 2024 |
KUCH JOHN J Chief Financial Officer | Sale at price 23.43 per share. | Direct | 104,821 | Mar 5, 2024 |
VALENTE NANCY M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 5, 2024 |
DESJARLAIS JOHN R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 5, 2024 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 5, 2024 |
Related Tickers
KYMR Kymera Therapeutics, Inc.
30.20
-0.17%
IDYA IDEAYA Biosciences, Inc.
18.08
+1.46%
CGEM Cullinan Therapeutics, Inc.
7.71
+2.80%
VRDN Viridian Therapeutics, Inc.
12.82
-0.93%
ZBIO Zenas BioPharma, Inc.
11.01
+5.16%
CNTA Centessa Pharmaceuticals plc
12.26
-2.00%
KZR Kezar Life Sciences, Inc.
4.0300
-0.98%
GLUE Monte Rosa Therapeutics, Inc.
4.1100
+3.27%
AVBP ArriVent BioPharma, Inc.
19.35
-0.05%
OLMA Olema Pharmaceuticals, Inc.
4.8000
+1.91%